Current Landscape of Immunotherapy for Advanced Sarcoma

SIMPLE SUMMARY: The systemic treatment of advanced sarcoma remains challenging. Conventional chemotherapy and anti-angiogenic agents, even in the most responsive histologic subtypes, result in short responses and poor clinical outcomes. In a context where new therapeutic approaches are required, sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Albarrán, Víctor, Villamayor, María Luisa, Pozas, Javier, Chamorro, Jesús, Rosero, Diana Isabel, San Román, María, Guerrero, Patricia, Pérez de Aguado, Patricia, Calvo, Juan Carlos, García de Quevedo, Coral, González, Carlos, Vaz, María Ángeles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136499/
https://www.ncbi.nlm.nih.gov/pubmed/37190214
http://dx.doi.org/10.3390/cancers15082287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136499/
https://www.ncbi.nlm.nih.gov/pubmed/37190214
http://dx.doi.org/10.3390/cancers15082287

Ejemplares similares